 This phenomenon is called antiandrogen withdrawal syndrome (AWS) and is one of the major drawbacks of existing antiandrogens.AWS is defined as tumor regression or symptomatic relief observed upon discontinuation of the antiandrogen therapy.The mechanism for this is not fully understood but current theories include alterations of the AR gene, coregulator proteins and/or signal transduction pathways.